MAIA Biotechnology Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2025 Annual Meeting ...

Scientists have synthesized new molecules with anticancer and antioxidant activity. ScienceDaily . Retrieved April 3, 2025 from www.sciencedaily.com / releases / 2016 / 03 / 160315104652.htm ...

This study provides the assessment of combined anticancer (engineered) and antibacterial (natural) phage activity in therapies. Materials & methods: An in vivo BALB/c mouse model of 4T1 tumor ...

Researchers discover that some low-affinity immunomodulatory antibodies have greater anticancer activity than those with high affinity. Antibodies’ ability to bind specifically and tightly to target ...

Study: Exploring the antimicrobial, antioxidant, anticancer, biocompatibility, and larvicidal activities of selenium nanoparticles fabricated by endophytic fungal strain Penicillium verhagenii.

Data from in vivo studies of the experimental drug demonstrated potent anticancer activity and improved survival in a mouse intracranial xenograft model implanted with both EGFR (epidermal ...

Fractions were screened for anticancer activity and those found active were pooled to get 400 mg semi-pure compound. The final purification was achieved by reverse phase preparative HPLC using ...

The poster is scheduled for presentation on May ... could become a best-in-class anticancer treatment with the potential to challenge the standard of care for NSCLC,” said MAIA CEO Vlad Vitoc ...